AYR Wellness Announces Filing of Q1 2025 Interim Financial Statements and MD&A
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, has announced the filing of its unaudited interim financial statements and Management's Discussion and Analysis (MD&A) for Q1 2025. The documents are now available on SEDAR+ and SEC's EDGAR system.
The company provided definitions of non-GAAP measures used in their reporting, including "Adjusted EBITDA" and "Adjusted Gross Profit". These metrics are used to evaluate business performance and capital structure, offering investors additional perspectives on operational decision-making.
AYR Wellness (OTCQX: AYRWF), una delle principali aziende statunitensi operanti in più stati nel settore della cannabis, ha annunciato la presentazione dei suoi stati patrimoniali intermedi non revisionati e del Management's Discussion and Analysis (MD&A) per il primo trimestre 2025. I documenti sono ora disponibili su SEDAR+ e sul sistema EDGAR della SEC.
L'azienda ha fornito definizioni delle misure non-GAAP utilizzate nel reporting, tra cui "Adjusted EBITDA" e "Adjusted Gross Profit". Queste metriche sono impiegate per valutare la performance aziendale e la struttura del capitale, offrendo agli investitori ulteriori prospettive sul processo decisionale operativo.
AYR Wellness (OTCQX: AYRWF), un operador líder de cannabis con presencia en varios estados de EE. UU., ha anunciado la presentación de sus estados financieros interinos no auditados y del Management's Discussion and Analysis (MD&A) para el primer trimestre de 2025. Los documentos ya están disponibles en SEDAR+ y el sistema EDGAR de la SEC.
La empresa proporcionó definiciones de las medidas no GAAP utilizadas en sus informes, incluyendo "Adjusted EBITDA" y "Adjusted Gross Profit". Estas métricas se utilizan para evaluar el rendimiento comercial y la estructura de capital, ofreciendo a los inversores perspectivas adicionales sobre la toma de decisiones operativas.
AYR Wellness (OTCQX: AYRWF), 다주 주에 걸친 미국 선두 대마초 운영기업으로서, 2025년 1분기 무감사 중간 재무제표 및 경영진의 분석 및 논의(MD&A)의 제출을 발표했습니다. 문서는 이제 SEDAR+ 및 SEC의 EDGAR 시스템에서 확인 가능합니다.
회사는 보고에 사용된 비GAAP 지표의 정의를 제공했으며, 여기에는 "Adjusted EBITDA"와 "Adjusted Gross Profit"이 포함됩니다. 이 지표들은 기업의 성과 및 자본 구조를 평가하는 데 사용되며, 투자자들에게 운영 의사 결정에 대한 추가 관점을 제공합니다.
AYR Wellness (OTCQX: AYRWF), un important opérateur américain de cannabis présent dans plusieurs États, a annoncé le dépôt de ses états financiers intermédiaires non audités et du Management's Discussion and Analysis (MD&A) pour le premier trimestre 2025. Les documents sont désormais disponibles sur SEDAR+ et le système EDGAR de la SEC.
L'entreprise a fourni les définitions des mesures non-GAAP utilisées dans leur reporting, notamment "Adjusted EBITDA" et "Adjusted Gross Profit". Ces indicateurs sont utilisés pour évaluer la performance de l'entreprise et la structure du capital, offrant aux investisseurs des perspectives supplémentaires sur la prise de décision opérationnelle.
AYR Wellness (OTCQX: AYRWF), ein führender US- Cannabis-Betreiber mit Mehrstaatenbetrieb, hat die Einreichung seiner ungeprüften Zwischenfinanzberichte und des Management's Discussion and Analysis (MD&A) für Q1 2025 bekannt gegeben. Die Dokumente sind jetzt auf SEDAR+ und dem EDGAR-System der SEC verfügbar.
Das Unternehmen hat Definitionen von Non-GAAP-Maßnahmen bereitgestellt, die in ihrem Reporting verwendet werden, darunter "Adjusted EBITDA" und "Adjusted Gross Profit". Diese Kennzahlen dienen der Bewertung der Unternehmensleistung und der Kapitalstruktur und bieten Investoren zusätzliche Perspektiven auf operative Entscheidungen.
AYR Wellness (OTCQX: AYRWF)، مشغل القنب الصناعي الأمريكي الرائد عبر عدة ولايات، أعلن تقديم بياناته المالية المرحلية غير المدققة وتحليل الإدارة ومناقشتها (MD&A) للربع الأول من 2025. الوثائق متاحة الآن على SEDAR+ ونظام EDGAR الخاص بالهيئة SEC.
قدمت الشركة تعريفات لمقاسات غير-GAAP المستخدمة في تقاريرها، بما في ذلك "Adjusted EBITDA" و "Adjusted Gross Profit". تُستخدم هذه المقاييس لتقييم أداء الأعمال وهيكل رأس المال، وتوفر للمستثمرين وجهات نظر إضافية حول اتخاذ القرار التشغيلي.
AYR Wellness (OTCQX: AYRWF)，一家在美国多州运营的领先大麻行业企业，宣布提交其未审计的中期财务报表及管理层讨论与分析（MD&A），覆盖2025年第一季度。相关文件现已在SEDAR+和SEC的EDGAR系统上提供。
公司提供了在报告中使用的非GAAP指标的定义，包括"Adjusted EBITDA"和"Adjusted Gross Profit"。这些指标用于评估业务表现和资本结构，为投资者提供对运营决策的额外视角。
- None.
- None.
MIAMI, Sept. 12, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announces that it has filed its unaudited interim condensed consolidated financial statements for the three months ended March 31, 2025, together with the related Management’s Discussion and Analysis (“MD&A”).
The Q1 2025 interim financial statements and MD&A are now available for review under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the U.S. Securities and Exchange Commission’s EDGAR system at www.sec.gov. These documents should be read in conjunction with Ayr’s most recent audited annual financial statements and accompanying notes.
Shareholders and interested parties are encouraged to review the filed materials in their entirety for complete information regarding the Company’s operating performance, liquidity position, and recent corporate developments.
Definition and Reconciliation of Non-GAAP Measures
The Company reports certain non-GAAP measures that are used to evaluate the performance of such businesses and the performance of their respective states, as well as to manage their capital structure. As non-GAAP measures generally do not have a standardized meaning, they may not be comparable to similar measures presented by other issuers. Securities regulations require such measures to be clearly defined and reconciled with their most directly comparable GAAP measure.
The Company references non-GAAP measures, including cannabis industry metrics, in the MD&A and elsewhere. These are provided as additional information to complement those GAAP measures by providing further understanding of the results of the operations of the Company from management’s perspective. Accordingly, these measures should not be considered in isolation, nor as a substitute for analysis of the Company’s financial information reported under GAAP. Non-GAAP measures used to analyze the performance of the Company include “Adjusted EBITDA” and “Adjusted Gross Profit”.
The Company believes that these non-GAAP financial measures may be useful to investors because they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making. These financial measures are intended to highlight trends in the Company’s core businesses that may not otherwise be apparent when solely relying on the GAAP measures.
Adjusted EBITDA
“Adjusted EBITDA” represents (loss) income from continuing operations, as reported under GAAP, before interest and taxes, adjusted to exclude non-core costs, other non-cash items, including depreciation and amortization and further adjusted to remove non-cash stock-based compensation, impairment expense, the incremental costs to acquire cannabis inventory in a business combination (when applicable; none of which was incurred for any of the periods presented), acquisition and transaction related costs, and start-up costs.
Adjusted Gross Profit
“Adjusted Gross Profit” represents gross profit, as reported under GAAP, adjusted to exclude the incremental costs to acquire cannabis inventory in a business combination (when applicable; none of which was incurred for any of the periods presented), interest, depreciation and amortization, start-up costs and other non-core costs.
Reconciliations of such non-GAAP measures are provided in the MD&A.
Forward-Looking Statements
Certain statements contained in this news release may contain forward-looking information or may be forward-looking statements (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as "target," "expect," "anticipate," "believe," "foresee," "could," "would," "estimate," "goal," "outlook," "intend," "plan," "seek," "will," "may," "tracking," "pacing," and "should" and similar expressions or words suggesting future outcomes. Numerous risks and uncertainties could cause actual events and results to differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those anticipated. AYR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
About AYR Wellness Inc.
AYR Wellness is a vertically integrated, U.S. multi-state cannabis business. The Company operates simultaneously as a retailer with 90+ licensed dispensaries and a house of cannabis CPG brands.
AYR is committed to delivering high-quality cannabis products to its patients and customers while acting as a Force for Good for its team members and the communities that the Company serves. For more information, please visit www.ayrwellness.com.
Company/Media Contact:
Robert Vanisko
SVP, Public Affairs
T: (786) 885-0397
Email: comms@ayrwellness.com
Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
T: (786) 885-0397
FAQ
Where can investors access AYR Wellness (AYRWF) Q1 2025 financial statements?
What non-GAAP measures does AYR Wellness (AYRWF) use in its financial reporting?
What period does AYR Wellness (AYRWF) Q1 2025 report cover?
How does AYR Wellness define Adjusted EBITDA?
